Pharmaceutical

Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxia

Health Canada has granted approval for Biogen’s Skyclarys to treat Friedreich’s ataxia (FA) in individuals aged 16 years and above.

Mar 19, 2025 - 06:00
Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxia
Health Canada has granted approval for Biogen’s Skyclarys to treat Friedreich’s ataxia (FA) in individuals aged 16 years and above.
Read the original article

Tags:

Previous Article

Curevo procures $110m and former-GSK exec for shingles vaccine candidate

Next Article

Big tech meets biotech: Recursion and the AI gold rush in pharma 

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Supreme Court strikes down use of affirmative action, a blow to efforts to diversify medical schools

STAT+: Supreme Court strikes down use of affirmative ac...

Jul 2, 2023

Opinion: What STAT’s opinion section is trying to do

Opinion: What STAT’s opinion section is trying to do

Nov 11, 2023

Japan grants patent for BioArctic’s Parkinson’s disease antibody

Japan grants patent for BioArctic’s Parkinson’s disease...

Aug 24, 2023